ReWalk Robotics Ltd. - Ordinary Shares LFWD 深 沪
等待开盘 07-18 09:30:00 美东时间
0.7436
+0.004
+0.49%
华盛通- 最 高0.773
- 今 开0.745
- 成交量 40.83万股
- 最 低 0.73
- 昨 收 0.74
- 总市值 818.53万
- 52周最高 4.77
- 市盈率 静 --
- 换手率 3.71%
- 52周最低 0.501
- 委 比 -97.63%
- 总股本 1100.76万
- 历史最高 7648.55
- 量 比 0.86
- 振 幅 5.81%
- 历史最低 0.501
- 每 手 1
- 风险率 0.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股机会日报 | 超1000亿美元蓄势待发！美股或迎巨量买盘；特朗普酝酿提前“换帅”逼宫美联储降
标普500期货涨0.33%创历史新高！超1000亿美元蓄势待发，美股或迎巨量买盘；特朗普酝酿提前“换帅”逼宫美联储降息>>
06-26 20:09
美股盘前 | 美光科技绩后涨超2%；量子计算概念股走高
美光科技绩后涨超2%，Q4营收、利润指引超预期；量子计算概念股走高，IONQ涨超4%，QUBT涨超2%；部分热门中概股上涨，哔哩哔哩、霸王茶姬涨超1%>>
06-26 16:32
Lifeward stock plummets on pricing of $2.6M public offering
Lifeward (NASDAQ:LFWD) has announced the pricing of a public offering of an aggregate of 4M of the Co.’s ordinary shares and accompanying warrants to purchase up to 4M of the Co.’s ordinary shares, at...
06-25 21:17
Lifeward Prices $2.6M Public Offering Of 4M Shares And Warrants At A Combined Price Of $0.65
Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the pricing of a
06-25 21:12
Lifeward Announces Pricing of $2.6 Million Public Offering
Lifeward Ltd. has announced a public offering of 4 million ordinary shares and warrants, priced at $0.65 each, with expected gross proceeds of $2.6 million. The warrants, exercisable immediately, expire in five years. Proceeds will support commercial efforts, working capital, and general corporate purposes. The offering is underwritten by H.C. Wainwright & Co. and registered with the SEC. Lifeward focuses on innovative medical technologies for in...
06-25 13:10
Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary
A recent ruling by an Administrative Law Judge (ALJ) has determined that the ReWalk Exoskeleton, developed by Lifeward Ltd., is a "reasonable and necessary" medical device for individuals with spinal cord injuries (SCI), allowing Medicare coverage for its use. This decision, which supports the medical necessity of the device, follows an April 2024 CMS ruling to finalize Medicare reimbursement for personal exoskeletons. The ReWalk Exoskeleton enab...
06-24 20:05
Lifeward appoints Mark Grant as CEO
Lifeward (NASDAQ:LFWD) announced on Monday that Mark Grant has been appointed as the company’s new president and chief executive officer, effective June 2, 2025. Larry Jasinski, Lifeward’s outgoing CE...
05-19 21:03
Lifeward Appoints Mark Grant As President And CEO, Effective June 2, 2025
Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that Mark Grant has
05-19 20:36
Lifeward Affirms FY2025 Sales Guidance of $28.00M-$30.00M vs $28.98M Est
Lifeward (NASDAQ:LFWD) affirms FY2025 sales outlook from $28.00 million-$30.00 million to $28.00 million-$30.00 million vs $28.98 million estimate.
05-15 20:03
Rewalk Robotics Q1 Adj. EPS $(0.44) Misses $(0.38) Estimate, Sales $5.03M Miss $5.75M Estimate
Rewalk Robotics (NASDAQ:LFWD) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.38) by 15.79 percent. This is a 29.03 percent increase over losses of $(0.62) per share from
05-15 20:02
